Cinclus Pharma Holding AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Feb '25 Feb 20, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	744	995	-	-	-	-	Upgrade
Enterprise Value	178	351	-	-	-	-	Upgrade
Last Close Price	16.00	21.38	-	-	-	-	Upgrade
PS Ratio	129.26	217.24	-	-	-	-	Upgrade
PB Ratio	1.34	1.79	-	-	-	-	Upgrade
P/TBV Ratio	1.79	1.79	-	-	-	-	Upgrade
EV/Sales Ratio	38.86	76.67	-	-	-	-	Upgrade
Debt / Equity Ratio	0.00	0.00	-1.71	0.00	0.01	-	Upgrade
Asset Turnover	0.01	0.01	0.04	0.06	-	-	Upgrade
Quick Ratio	12.50	12.50	0.56	3.99	7.17	32.17	Upgrade
Current Ratio	13.20	13.20	0.57	4.01	7.47	32.75	Upgrade
Return on Equity (ROE)	-70.23%	-70.23%	-859.20%	-196.14%	-45.79%	-39.33%	Upgrade
Return on Assets (ROA)	-30.49%	-30.49%	-89.35%	-79.11%	-29.29%	-21.50%	Upgrade
Return on Capital (ROIC)	-34.77%	-34.77%	-137.82%	-102.90%	-31.49%	-22.49%	Upgrade
Earnings Yield	-22.57%	-16.89%	-	-	-	-	Upgrade
FCF Yield	-17.93%	-17.93%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-41.12%	-41.12%	-13.81%	-9.26%	-8415.70%	-	Upgrade
Total Shareholder Return	-41.12%	-41.12%	-13.81%	-9.26%	-8415.70%	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.